Advertisement
UK markets open in 5 hours 33 minutes
  • NIKKEI 225

    38,363.46
    +161.09 (+0.42%)
     
  • HANG SENG

    18,313.86
    0.00 (0.00%)
     
  • CRUDE OIL

    79.22
    +0.23 (+0.29%)
     
  • GOLD FUTURES

    2,316.70
    -5.60 (-0.24%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • Bitcoin GBP

    49,216.93
    -843.31 (-1.68%)
     
  • CMC Crypto 200

    1,309.88
    +15.20 (+1.17%)
     
  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     
  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     

Examining Pfizer’s Valuation as of August 6

Examining Pfizer’s Valuation as of August 6

Pfizer (PFE) is focused on discovering, developing, and manufacturing healthcare products. Pfizer’s portfolio includes medicines, vaccines, and consumer healthcare products. Pfizer’s top line rose ~4% to $13.5 billion in the second quarter of 2018 compared to $12.9 billion in the second quarter of 2017.